Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Serosurveillance of First-Year Military Personnel for Hepatitis A and B.

Broderick M, Kamili S, Nelson NP, Le T, Faix D, Romero-Steiner S.

Am J Public Health. 2018 Sep;108(S3):S204-S206. doi: 10.2105/AJPH.2018.304713. No abstract available.

2.

School District Crisis Preparedness, Response, and Recovery Plans - United States, 2012.

Silverman B, Chen B, Brener N, Kruger J, Krishna N, Renard P Jr, Romero-Steiner S, Avchen RN.

MMWR Morb Mortal Wkly Rep. 2016 Sep 16;65(36):949-53. doi: 10.15585/mmwr.mm6536a2.

3.

Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.

Broderick MP, Romero-Steiner S, Rajam G, Johnson SE, Milton A, Kim E, Choi LJ, Radin JM, Schmidt DS, Carlone GM, Messonnier N, Faix DJ.

Clin Vaccine Immunol. 2016 Aug 5;23(8):672-80. doi: 10.1128/CVI.00267-16. Print 2016 Aug.

4.

Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.

Nix EB, Williams K, Cox AD, St Michael F, Romero-Steiner S, Schmidt DS, McCready WG, Ulanova M.

Emerg Infect Dis. 2015 Feb;21(2):273-9. doi: 10.3201/eid2102.140722.

5.

Effect of multiple, simultaneous vaccines on polio seroresponse and associated health outcomes.

Broderick MP, Oberste MS, Moore D, Romero-Steiner S, Hansen CJ, Faix DJ.

Vaccine. 2015 Jun 4;33(24):2842-8. doi: 10.1016/j.vaccine.2014.07.088. Epub 2014 Aug 12.

PMID:
25131729
6.

Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel.

Patel M, Romero-Steiner S, Broderick MP, Thomas CG, Plikaytis BD, Schmidt DS, Johnson SE, Milton AS, Carlone GM, Clark TA, Messonnier NE, Cohn AC, Faix DJ.

Vaccine. 2014 Jun 24;32(30):3805-9. doi: 10.1016/j.vaccine.2014.05.001. Epub 2014 May 14.

7.

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.

Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B.

Nat Immunol. 2014 Feb;15(2):195-204. doi: 10.1038/ni.2789. Epub 2013 Dec 15.

8.

Absence of high molecular weight proteins 1 and/or 2 is associated with decreased adherence among non-typeable Haemophilus influenzae clinical isolates.

Vuong J, Wang X, Theodore JM, Whitmon J, Gomez de Leon P, Mayer LW, Carlone GM, Romero-Steiner S.

J Med Microbiol. 2013 Nov;62(Pt 11):1649-56. doi: 10.1099/jmm.0.058222-0. Epub 2013 Aug 29.

PMID:
23988628
9.

Phenotypic, genomic, and transcriptional characterization of Streptococcus pneumoniae interacting with human pharyngeal cells.

Kimaro Mlacha SZ, Romero-Steiner S, Hotopp JC, Kumar N, Ishmael N, Riley DR, Farooq U, Creasy TH, Tallon LJ, Liu X, Goldsmith CS, Sampson J, Carlone GM, Hollingshead SK, Scott JA, Tettelin H.

BMC Genomics. 2013 Jun 9;14:383. doi: 10.1186/1471-2164-14-383.

10.

Transcriptional adaptation of pneumococci and human pharyngeal cells in the presence of a virus infection.

Kimaro Mlacha SZ, Peret TC, Kumar N, Romero-Steiner S, Dunning Hotopp JC, Ishmael N, Grinblat-Huse V, Riley DR, Erdman DD, Carlone GM, Sampson J, Scott JA, Tettelin H.

BMC Genomics. 2013 Jun 7;14:378. doi: 10.1186/1471-2164-14-378.

11.

Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera.

Schmidt DS, Bieging KT, Gomez-de-León P, Villaseñor-Sierra A, Inostroza J, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S.

Pediatr Infect Dis J. 2012 Aug;31(8):876-8. doi: 10.1097/INF.0b013e31825ab166.

12.

Establishment of a new human pneumococcal standard reference serum, 007sp.

Goldblatt D, Plikaytis BD, Akkoyunlu M, Antonello J, Ashton L, Blake M, Burton R, Care R, Durant N, Feavers I, Fernsten P, Fievet F, Giardina P, Jansen K, Katz L, Kierstead L, Lee L, Lin J, Maisonneuve J, Nahm MH, Raab J, Romero-Steiner S, Rose C, Schmidt D, Stapleton J, Carlone GM.

Clin Vaccine Immunol. 2011 Oct;18(10):1728-36. doi: 10.1128/CVI.05252-11. Epub 2011 Aug 18.

13.

Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness.

Hammitt LL, Bulkow LR, Singleton RJ, Nuorti JP, Hummel KB, Miernyk KM, Zanis C, Whaley M, Romero-Steiner S, Butler JC, Rudolph K, Hennessy TW.

Vaccine. 2011 Mar 9;29(12):2287-95. doi: 10.1016/j.vaccine.2011.01.029. Epub 2011 Jan 19.

PMID:
21255685
14.

Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a.

Rouphael NG, Satola S, Farley MM, Rudolph K, Schmidt DS, Gomez-de-León P, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S.

Clin Vaccine Immunol. 2011 Feb;18(2):243-7. doi: 10.1128/CVI.00219-10. Epub 2010 Dec 22.

15.

Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.

Rose CE, Romero-Steiner S, Burton RL, Carlone GM, Goldblatt D, Nahm MH, Ashton L, Haston M, Ekström N, Haikala R, Käyhty H, Henckaerts I, Durant N, Poolman JT, Fernsten P, Yu X, Hu BT, Jansen KU, Blake M, Simonetti ER, Hermans PW, Plikaytis BD.

Clin Vaccine Immunol. 2011 Jan;18(1):135-42. doi: 10.1128/CVI.00370-10. Epub 2010 Nov 17.

16.

Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharides.

Whaley MJ, Rose C, Martinez J, Laher G, Sammons DL, Smith JP, Snawder JE, Borrow R, Biagini RE, Plikaytis B, Carlone GM, Romero-Steiner S.

Clin Vaccine Immunol. 2010 May;17(5):862-9. doi: 10.1128/CVI.00022-10. Epub 2010 Mar 24.

17.

Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model.

Whaley MJ, Sampson JS, Johnson SE, Rajam G, Stinson-Parks A, Holder P, Mauro E, Romero-Steiner S, Carlone GM, Ades EW.

Vaccine. 2010 Apr 19;28(18):3071-5. doi: 10.1016/j.vaccine.2010.02.086. Epub 2010 Mar 4.

PMID:
20206671
18.

Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.

Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.

J Infect Dis. 2010 Feb 15;201(4):525-33. doi: 10.1086/651131.

PMID:
20088694
19.

Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure.

O'Brien KL, Moïsi J, Romero-Steiner S, Holder P, Carlone GM, Reid R, Santosham M.

Vaccine. 2009 Mar 13;27(12):1863-8. doi: 10.1016/j.vaccine.2008.12.060. Epub 2009 Jan 24.

PMID:
19171175
20.

A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization.

Rajam G, Phillips DJ, White E, Anderton J, Hooper CW, Sampson JS, Carlone GM, Ades EW, Romero-Steiner S.

Microb Pathog. 2008 Mar;44(3):186-96. Epub 2007 Oct 5.

PMID:
17997274
21.

Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C.

Rajam G, Carlone GM, Romero-Steiner S.

Clin Vaccine Immunol. 2007 Sep;14(9):1223-7. Epub 2007 Jul 3.

22.

An in vitro model to assess pneumococcal adherence to nasopharyngeal cells under competition conditions.

Rajam G, Jackson D, Pilishvili T, Whitney CG, Facklam RR, Carlone GM, Romero-Steiner S.

J Microbiol Methods. 2007 Aug;70(2):219-26. Epub 2007 Apr 24.

PMID:
17512994
23.

E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae.

Anderton JM, Rajam G, Romero-Steiner S, Summer S, Kowalczyk AP, Carlone GM, Sampson JS, Ades EW.

Microb Pathog. 2007 May-Jun;42(5-6):225-36. Epub 2007 Feb 27.

PMID:
17412553
24.

Haemophilus influenzae type a infection and its prevention.

Jin Z, Romero-Steiner S, Carlone GM, Robbins JB, Schneerson R.

Infect Immun. 2007 Jun;75(6):2650-4. Epub 2007 Mar 12. Review. No abstract available.

25.

Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults.

Dentinger CM, Hennessy TW, Bulkow LR, Reasonover AL, Romero-Steiner S, Holder PF, de Leon PG, Carlone GM, Parks DJ, Parkinson AJ, Singleton RJ, Levine OS, Butler JC.

Hum Vaccin. 2006 Jan-Feb;2(1):24-8. Epub 2006 Jan 18.

PMID:
17012896
26.

Assessment of carriage of Haemophilus influenzae type a after a case of invasive disease.

Hammitt LL, Hennessy TW, Romero-Steiner S, Butler JC.

Clin Infect Dis. 2006 Aug 1;43(3):386-7. No abstract available.

PMID:
16804859
27.

Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.

Baggett HC, Hennessy TW, Bulkow L, Romero-Steiner S, Hurlburt D, Holder P, Parkinson AJ, Singleton RJ, Levine O, Carlone GM, Butler JC.

Clin Vaccine Immunol. 2006 Jun;13(6):620-6.

28.

Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae.

Martinez JE, Clutterbuck EA, Li H, Romero-Steiner S, Carlone GM.

Clin Vaccine Immunol. 2006 Apr;13(4):459-66.

29.

Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies.

Romero-Steiner S, Caba J, Rajam G, Langley T, Floyd A, Johnson SE, Sampson JS, Carlone GM, Ades E.

Vaccine. 2006 Apr 12;24(16):3224-31. Epub 2006 Feb 2.

PMID:
16487631
30.

Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines.

Romero-Steiner S, Frasch CE, Carlone G, Fleck RA, Goldblatt D, Nahm MH.

Clin Vaccine Immunol. 2006 Feb;13(2):165-9. Review. No abstract available.

31.

Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae.

Bieging KT, Rajam G, Holder P, Udoff R, Carlone GM, Romero-Steiner S.

Clin Diagn Lab Immunol. 2005 Oct;12(10):1238-42.

32.

Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies.

Romero-Steiner S, Holder PF, Gomez de Leon P, Spear W, Hennessy TW, Carlone GM.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1029-35.

33.

No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.

Baggett HC, Rhodes JC, Fridkin SK, Quinn CP, Hageman JC, Friedman CR, Dykewicz CA, Semenova VA, Romero-Steiner S, Elie CM, Jernigan JA.

Clin Infect Dis. 2005 Oct 1;41(7):991-7. Epub 2005 Aug 29.

PMID:
16142664
34.

Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity.

Kolibab K, Smithson SL, Shriner AK, Khuder S, Romero-Steiner S, Carlone GM, Westerink MA.

Immun Ageing. 2005 Jun 27;2:10.

35.

Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine.

Musher DM, Ceasar H, Kojic EM, Musher BL, Gathe JC Jr, Romero-Steiner S, White AC Jr.

J Infect Dis. 2005 Apr 1;191(7):1063-7. Epub 2005 Feb 28.

PMID:
15747240
36.

Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies.

Fleck RA, Romero-Steiner S, Nahm MH.

Clin Diagn Lab Immunol. 2005 Jan;12(1):19-27. Review. No abstract available.

37.

A murine model for the study of immune memory in response to pneumococcal conjugate vaccination.

Moreno RL, Sampson JS, Romero-Steiner S, Wong B, Johnson SE, Ades E, Carlone GM.

Vaccine. 2004 Aug 13;22(23-24):3069-79.

PMID:
15297057
38.

Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.

Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, Holder PF, O'Brien WA, Whitney CG, Butler JC, Breiman RF.

Clin Diagn Lab Immunol. 2004 Jan;11(1):137-41.

39.

Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator.

Romero-Steiner S, Spear W, Brown N, Holder P, Hennessy T, Gomez De Leon P, Carlone GM.

Clin Diagn Lab Immunol. 2004 Jan;11(1):89-93.

40.

Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.

Romero-Steiner S, Frasch C, Concepcion N, Goldblatt D, Käyhty H, Väkeväinen M, Laferriere C, Wauters D, Nahm MH, Schinsky MF, Plikaytis BD, Carlone GM.

Clin Diagn Lab Immunol. 2003 Nov;10(6):1019-24.

41.

Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.

Romero-Steiner S, Pilishvili T, Sampson JS, Johnson SE, Stinson A, Carlone GM, Ades EW.

Clin Diagn Lab Immunol. 2003 Mar;10(2):246-51.

42.
43.

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E, Pruckler J, Schwartz S, Benson RF, Helsel LO, Holder PF, Johnson SE, Kellum M, Messmer T, Thacker WL, Besser L, Plikaytis BD, Taylor TH Jr, Freeman AE, Wallace KJ, Dull P, Sejvar J, Bruce E, Moreno R, Schuchat A, Lingappa JR, Martin SK, Walls J, Bronsdon M, Carlone GM, Bajani-Ari M, Ashford DA, Stephens DS, Perkins BA.

Emerg Infect Dis. 2002 Oct;8(10):1103-10.

44.

Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.

Dewan PK, Fry AM, Laserson K, Tierney BC, Quinn CP, Hayslett JA, Broyles LN, Shane A, Winthrop KL, Walks I, Siegel L, Hales T, Semenova VA, Romero-Steiner S, Elie C, Khabbaz R, Khan AS, Hajjeh RA, Schuchat A; Washington, D.C., Anthrax Response Team.

Emerg Infect Dis. 2002 Oct;8(10):1066-72.

45.

Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.

Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, Semenova VA, Romero-Steiner S, Elie C, Quinn CP, Khabbaz R, Khan AS, Martin G, Eisold J, Schuchat A, Hajjeh RA.

Emerg Infect Dis. 2002 Oct;8(10):1039-43.

46.
47.

Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.

Martinez J, Pilishvili T, Barnard S, Caba J, Spear W, Romero-Steiner S, Carlone GM.

Clin Diagn Lab Immunol. 2002 Mar;9(2):485-8.

48.

Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate).

Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Sanchez J, Feris J, Balter S, Levine OS, Carlone GM.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1115-9.

49.

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults.

Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, Holder PF, O'Brien WA, Whitney CG, Butler JC, Breiman RF.

Vaccine. 2001 Nov 12;20(3-4):545-53.

PMID:
11672921
50.

Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine.

Fernández J, Balter S, Feris J, Gómez E, Garib Z, Castellanos PL, Sánchez J, Romero-Steiner S, Levine OS.

Am J Trop Med Hyg. 2000 Apr;62(4):485-90.

PMID:
11220764

Supplemental Content

Loading ...
Support Center